also reported that the incidence of liver metastasis is significantly different between subtypes with the EGFR exon 19 deletion versus the exon 21 mutation, highlighting the potential association of molecular profiling in the spread of NSCLC tumors (5). This evidence concerns the gene EGFR and non-small cell lung carcinoma.